On top of noninferior efficacy, the trial showed patients had less bleeding with 2.5 mg vs 5.0 mg twice daily over 12 months.
Results show noninferiority to a full dose in preventing a recurrence of blood clots and an advantage when it comes to ...
Data from the ATLAS research comprises a series of trials that have yielded years of long-term, comprehensive data on safety ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
These include: apixaban rivaroxaban edoxaban dabigatran injectable anticoagulants, also known as low molecular weight heparins. The most common side effects of all anticoagulants are bleeding and ...
The S5 EV measures 4476mm long, 1849mm wide and 1621mm-1626mm tall on a 2730mm wheelbase. That makes it 21mm longer than a BYD Atto 3 on a 10mm longer wheelbase. According to local documents, tare ...
Looking for a great Android tablet? We've got you covered, thanks to the results of our independent lab tests. The real difference when you're looking for the best Android tablet comes in the hardware ...
Google has launched a native Linux Terminal app for Android, allowing users to run Debian in a virtual machine, primarily benefiting developers, security professionals, and those needing Linux ...
one of the biggest changes is that this will be TCL's first AI-powered tablet. The 11.5-inch device will feature various AI functionalities woven into apps, including Text Assist, Writing Assist ...
After 2 days of treatment, your child’s doctor may increase the dosage for your child to 5 mg once per day. After another 2 days, they may increase your child’s dosage to 10 mg once per day.
It's been a long time since Apple's iPad lineup was worthy of a dedicated press conference — last year's iPad Pro announcement was the rare time the company's tablets can stand on their own.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results